Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
{{output}}
Background: Neuregulin 1 (NRG1) fusions are recurrent oncogenic drivers found in multiple solid tumors. NRG1 binds to human epidermal growth factor receptor 3 (HER3), leading to heterodimerization with HER2 and activation of down... ...
